Revenue | ₹77.23Cr |
Net Profits | ₹5.36Cr |
Net Profit Margins | 6.94% |
Balaxi Pharmaceuticals Ltd’s revenue jumped 23.98% since last year same period to ₹77.23Cr in the Q3 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 5.4% jump in its revenue since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit fell -60.56% since last year same period to ₹5.36Cr in the Q3 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 16.78% jump in its net profits since last 3-months.
Balaxi Pharmaceuticals Ltd’s net profit margin fell -68.19% since last year same period to 6.94% in the Q3 2024-2025. On a quarterly growth basis, Balaxi Pharmaceuticals Ltd has generated 10.79% jump in its net profit margins since last 3-months.
The revenue for Balaxi Pharmaceuticals Ltd in the Q3 results 2024 was ₹77.23Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q3 results 2024 was ₹5.36Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q3 results 2024 was 6.94%.
The revenue for Balaxi Pharmaceuticals Ltd in the Q3 results 2023 was ₹62.29Cr.
The net profit for Balaxi Pharmaceuticals Ltd in the Q3 results 2023 was ₹13.59Cr.
The net profit margin for Balaxi Pharmaceuticals Ltd in the Q3 results 2023 was 21.82%.